EMD-26373
SARS-2 CoV 6P Mut7 in complex with Fab CC84.2
EMD-26373
Single-particle25.0 Å
Deposition: 04/03/2022Map released: 27/04/2022
Last modified: 17/01/2024
Sample Organism:
Homo sapiens
Sample: SARS-2 CoV 6P Mut7 in complex with Fab CC84.2
Deposition Authors: Torres JL
,
Ward AB
Sample: SARS-2 CoV 6P Mut7 in complex with Fab CC84.2
Deposition Authors: Torres JL
,
Ward AB
Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses.
He WT ,
Musharrafieh R ,
Song G,
Dueker K ,
Tse LV ,
Martinez DR ,
Schafer A ,
Callaghan S,
Yong P ,
Beutler N ,
Torres JL ,
Volk RM,
Zhou P ,
Yuan M ,
Liu H ,
Anzanello F,
Capozzola T ,
Parren M ,
Garcia E ,
Rawlings SA,
Smith DM,
Wilson IA ,
Safonova Y ,
Ward AB ,
Rogers TF ,
Baric RS ,
Gralinski LE ,
Burton DR ,
Andrabi R
(2022) Nat Immunol , 23 , 960 - 970
,
Musharrafieh R ,
Song G,
Dueker K ,
Tse LV ,
Martinez DR ,
Schafer A ,
Callaghan S,
Yong P ,
Beutler N ,
Torres JL ,
Volk RM,
Zhou P ,
Yuan M ,
Liu H ,
Anzanello F,
Capozzola T ,
Parren M ,
Garcia E ,
Rawlings SA,
Smith DM,
Wilson IA ,
Safonova Y ,
Ward AB ,
Rogers TF ,
Baric RS ,
Gralinski LE ,
Burton DR ,
Andrabi R
(2022) Nat Immunol , 23 , 960 - 970
Grant Support:
- Bill & Melinda Gates Foundation: INV-004923 (United States)